Evidence map›Paper›PMID 42904423›Full record

ArticleBehavioral medicine (Washington, D.C.)

From Collection to Collaboration: Building Ethical Frameworks for Genetic Research.

Devin A Madden, Emerson Dusic, Isabella E Rios, Kimberly Zayhowski, L Jude Tantay, Nasa Sinnott-Armstrong, Rodrigo Aguayo-Romero, Sima Rabinowitz, Michelle A Ramos, Kellan Baker and 2 more

Abstract read
In one paragraph

Article in Behavioral medicine (Washington, D.C.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Devin A MaddenDepartment of Population Health Science and Policy, Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai.
Emerson DusicDepartment of Epidemiology, University of Michigan School of Public Health.
Isabella E RiosDepartment of Epidemiology, University of Michigan School of Public Health.
Kimberly ZayhowskiMedical Sciences and Education, Boston University Chobanian and Avedisian School of Medicine.
L Jude TantayL. Tantay Consulting.
Nasa Sinnott-ArmstrongPublic Health Sciences Division, Fred Hutchinson Cancer Center.
Rodrigo Aguayo-RomeroInstitute for Health Research & Policy at Whitman-Walker.
Sima RabinowitzDepartment of Population Health Science and Policy, Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai.
Michelle A RamosDepartment of Population Health Science and Policy, Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai.
Kellan BakerDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health.
Sari L ReisnerDepartment of Epidemiology, University of Michigan School of Public Health.
Carol R HorowitzDepartment of Population Health Science and Policy, Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai.

Funding

Transforming Genomics: Maximizing Community Input and ImpactR01HG013145 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Carol R Horowitz, Sari Reisner · 2023 to 2026
$3.2M
NHGRI NIH HHS R01 HG013145
6 · The paper itself

Abstract

Transgender, nonbinary, and gender diverse (TNGD) communities are not routinely included as partners in the research that will impact them. The expansion of genomic and gender identity data collection has allowed researchers to explore transgender identity genomics research (TIGR), or associations between genomics and gender identity. We used a community-based participatory research (CBPR) approach to explore TNGD perspectives on TIGR in order to advance ethical practices, minimize harms, and maximize potential benefits. An Executive Stakeholder Board of TNGD community members, advocates, clinicians, and ethics, legal, genomics, and health equity scholars co-developed recruitment strategies, data collection tools, analytic strategies, and a dissemination plan which informed qualitative interviews with 31 U.S.-based TNGD adults. The mean age was 34 years (range = 19-73). Twelve participants were nonbinary, 12 were trans women, and 7 were trans men. The majority (61%) were people of color. Using reflexive thematic analysis, we conceptualized four themes related to ethical TIGR research practices: 1) Are we represented? 2) Are we protected? 3) Are we benefiting? 4) Are we understood? Findings underscore the importance of conducting any TIGR or genomics research with and not on TNGD communities. Ethical research benefits from sustained partnership, transparency, and reflexivity, particularly amidst ideologically motivated threats to inclusive science. Centering TNGD voices in, and recommendations for, genomics strengthens both scientific rigor and community trust. The incongruity of attempting to interrupt a CBPR study focused on ethical research practices in TIGR underscores the contradiction between stated federal commitments to research integrity and the actions taken. (4,064 words).

Indexed as

Community-Based Participatory ResearchGenetic ResearchTransgender PersonsAdultAgedCooperative BehaviorData CollectionFemaleGender IdentityGender-Nonconforming PersonsGenomicsHumansMaleMiddle AgedYoung AdultCBPRcommunity-based participatory researchethicalgenomicsgenomics researchlegal and social implications of researchtransgendertransgender health

Identifiers

PMID42904423
PMCPMC13693425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.